This is to inform you that the Board Meeting of the Board of Directors of the Company is scheduled to be held on Monday, 27th March 2023, at 2.00 P.M. at 10/60, Industrial Area, Kirti Nagar, New Delhi-110015 .

Inter alia, to consider and approve :- 1. To Consider and approve AOP for FY 2023-24 2. To approve the sanction letter received from UBI for WC. 3. To reappoint Secretarial auditor for the FY 22-23

Independent Director Meeting

Inter alia, to consider and approve the following matters: 1. Appointment of Ms. Prity Bishwakarma, Company Secretary (Membership No. A63580), as a Company Secretary and Compliance Officer of the Company pursuant to Section 203 of the Companies Act, 2013 and Regulation 6(1) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 2. Any other matters with the permission of the Chairman

Inter alia, to consider and approve Appointment of Mr. Srinivas Rao Kandula as Director of the Company

Inter alia, to consider and approve:- 1. Conversion of warrants into equity shares to the Promoters pursuant to the allotment of the same in the board meeting held on 07.11.2022. 2. Acquisition of Proton Remedies Private Limited as approved by the shareholders in the Annual General Meeting held on 30.09.2022. 3. Any other business with the permission of the Chair.

Other business matters

Inter-alia, to consider and approve other items as per the agenda of the meeting.

Inter alia, to consider and approve issuance of unsecured redeemable non-convertible debentures, in various tranches, under a Shelf Placement Memorandum, aggregating Rs. 57,000 crore on a private placement basis, in accordance with the approval granted by the shareholders of the Corporation at the 45th Annual General Meeting held on June 30, 2022

Inter alia, to consider appointment of Woman Director (Independent) on the Board of the Company.

Independent Director Meeting

Inter alia, to consider and approve :- 1. To provide corporate guarantee to Nayas Laboratories Private Limited, subsidiary Company under Sec 186 of Companies Act, 2013. 2. To consider prior approval of the related party transaction i.e., providing corporate guarantee to Nayas Laboratories Private Limited, subsidiary Company. 3. Any other business with the permission of the Chair.

Independent Director Meeting

Other business matters

Independent Director Meeting

Quarterly Results

Independent Director Meeting

Inter alia, , to transact the following business: 1. To consider & approve the raising of funds by way of right issue (?Right Issue?), in accordance with the Companies Act, 2013 and the rules made there under, Securities Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other applicable laws. 2. To consider and approve the increase in Authorized Share Capital of the Company pursuant to Right Issue. 3. To consider any other matter with the permission of the Chair as the Board may think fit or which is incidental and ancillary to the business of the Company

Inter alia, to consider and approve Intimation of Board Meeting to consider the matter related to Corproate Term Loan pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Independent Director Meeting

Inter alia, to consider:- 1) To Approval of the Related Party Transactions for the year 2023-2024 2) Performance Meeting of Independent Director's of the Company 3) Any Other Matter as per per-view of Chairman

Inter alia, to consider the following business: 1. To review the performance of non-independent directors and the Board as a Whole. 2. To review the performance of the Chairperson of the company, taking into account the views of executive directors and non-executive directors; 3. To assess the quality, quantity, and timeliness of the flow of information between the company management and the Board that is necessary for the Board to effectively and reasonably perform their duties.

Independent Director Meeting

Independent Director Meeting Inter ala, to consider and approve:- 1. Review the performance of Non-Independent Directors and the Board of Directors as a whole, 2. Review the performance of the chairperson of the Company, 3. Assess the quality, quantity and timeliness of flow of information between the management of the Company and the board of directors that is necessary for the board of directors to effectively and reasonably perform their duties